NEUROIMAGING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)
Neuroimaging Market, By Technology (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Functional Magnetic Resonance Imaging (fMRI), Diffusion Tensor Imaging (DTI), Magnetoencephalography (MEG), Electroencephalography (EEG), and Others), By Application (Neurological Disorders, Psychiatric Disorders, Traumatic Brain Injury), By End User (Hospitals and Clinics, Diagnostic Centers, Research Institutes, Ambulatory Surgical Centers, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East)
The market growth in North America region is being driven by the increasing incidence of neurological disorders, such as Alzheimers disease, stroke, and brain tumors. The high level of healthcare expenditure and the presence of a large number of imaging centers are also contributing to the growth of the market. The market share of North America is expected to be 41.5% in 2023.
The market growth in Europe region is being driven by the factors similar to North America, as well as the presence of a large number of research institutes. The market share of Europe is expected to be 23.1% in 2023.
The market growth in Asia Pacific region is being driven by the increasing incidence of neurological disorders, the rising disposable income of people, and the increasing government funding for research and development. The market share of Asia Pacific is expected to be 18.6% in 2023.
Geographies covered:
North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East
U.S.: 
U.K. : 
India : 
